Publication Cover
Hemoglobin
international journal for hemoglobin research
Volume 40, 2016 - Issue 4
105
Views
3
CrossRef citations to date
0
Altmetric
Short Communication

Hb Tianshui (HBB: C.119A > G) in Compound Heterozygosity with Hb S (HBB: C.20A > T) from Odisha, India

, , , , , , & show all
Pages 270-272 | Received 19 Jul 2015, Accepted 06 Mar 2016, Published online: 02 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Satyabrata Meher, Snehadhini Dehury, Arpita Jana, Subhra Bhattacharya, Amrita Patel, Kishalaya Das, Siris Patel, Biswanath Sarkar & Pradeep Kumar Mohanty. (2016) First Report of Hb Limassol [β8(A5)Lys→Asn; HBB: c.27G>C] from Odisha, India. Hemoglobin 40:6, pages 422-424.
Read now

Articles from other publishers (2)

Pallavi Thaker, Namrata Mahajan, Malay B. Mukherjee & Roshan B. Colah. (2024) Wide spectrum of novel and rare hemoglobin variants in the multi‐ethnic Indian population: A review. International Journal of Laboratory Hematology 46:3, pages 434-450.
Crossref
Pradeep Kumar Mohanty, Satyabrata Meher, Snehadhini Dehury, Subhra Bhattacharya, Kishalaya Das, Siris Patel & Biswanath Sarkar. (2018) Compound heterozygote of Hb DIran [HBB: c.67G>C, β 22(B4) Glu>Gln] with β0-thalassemia [cds 41/42 (-CTTT)] from Eastern India. Hematology, Transfusion and Cell Therapy 40:1, pages 82-85.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.